Skip to content
Disclosery

Maple-Brown Abbott Ltd: DUK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on DUK, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 659,883 DUK shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 659,883 shares
    Change vs previous 13F +181,143 shares

    5.49% of the 13F portfolio, value $80,492,388.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 478,740 shares
    Change vs previous 13F -107,740 shares

    6.29% of the 13F portfolio, value $51,579,448.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 586,480 shares
    Change vs previous 13F -130,640 shares

    6.71% of the 13F portfolio, value $67,621,144.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 717,120 shares
    Change vs previous 13F -256,040 shares

    7.58% of the 13F portfolio, value $71,876,938.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 973,160 shares
    Change vs previous 13F -21,500 shares

    9.63% of the 13F portfolio, value $94,114,304.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 994,660 shares
    Change vs previous 13F -76,200 shares

    9.83% of the 13F portfolio, value $96,521,806.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 1,070,860 shares
    Change vs previous 13F -68,340 shares

    10.84% of the 13F portfolio, value $94,514,103.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 1,139,200 shares
    Change vs previous 13F not available

    11.36% of the 13F portfolio, value $102,231,808.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).